Editorial Board
Search
Search

Editorial Board

CR distinguishes itself as an inclusive and provocative vehicle that promotes collaborations between advocates and scientists that lead to results for cancer patients.

The cornerstone of this mission is an editorial board that is comprised of an equal number of advocates/survivors and physicians/scientists. These individuals are respected members of the cancer community who contribute their expertise and perspectives to guide and enrich the content of the magazine.

CR's editorial board currently includes the following members, who have been appointed to serve two-year terms:

Alex A. Adjei, MD, PhD, is the senior vice president of clinical research and the chairman of the department of medicine at the Roswell Park Cancer Institute in Buffalo, N.Y. His clinical and research programs focus on novel therapeutics for lung cancer and phase I clinical trials.

William P. Bro, is the president and chief executive officer of the Kidney Cancer Association. He is a member of the Director's Consumer Liaison Group at the National Cancer Institute and is on the board of the nonprofit organization Friends of Cancer Research. Bro, a 15-year survivor of stage I kidney cancer, lives in Evanston, Ill.

Sara A. Courtneidge, PhD, is a professor at the Burnham Institute in La Jolla, Calif., where she is the director of the program in Cell Adhesion and Extracellular Matrix Biology. Courtneidge's research focuses on the Src family of protein tyrosine kinases.

Jimmie C. Holland, MD, is an attending psychiatrist at Memorial Sloan-Kettering Cancer Center in New York City and a professor of psychiatry at Weill Medical College of Cornell University, also in New York City. Holland is recognized as the founder of the subspecialty of psycho-oncology. Starting in the mid-1970s, she conducted some of the first epidemiologic studies related to the prevalence and nature of psychological problems in patients with cancer.

Ronald Levy, MD, is a professor of medicine and chief of the oncology division at Stanford University School of Medicine in Stanford, Calif. Levy's research focuses on lymphoma and other cancers of the immune system.

H. Kim Lyerly, MD, is the George Barth Geller Professor of Research in Cancer and director of the Duke Comprehensive Cancer Center in Durham, N.C. He is a co-leader of the Breast and Ovarian Oncology Research Program at Duke and the principal investigator of the Duke Specialized Program in Research Excellence (SPORE) grant in breast cancer. His research interests focus on the surgical treatment of breast cancer and gene- and immune-based cancer therapies.

Lynn M. Matrisian, PhD, is the chair of the department of cancer biology and an Ingram Professor of Cancer Research at Vanderbilt University School of Medicine in Nashville, Tenn. Matrisian's research focuses on the molecular mechanisms underlying tumor progression and metastasis. She was president of the American Association for Cancer Research in 2004-2005.

Musa Mayer, a 17-year stage II breast cancer survivor, speaks, writes and consults on advocacy and survivorship issues, and works with women who have metastatic breast cancer. She is a patient representative/consultant at the FDA and serves on the Institute of Medicine Forum on Drug Discovery, Development and Translation. Mayer, who lives in New York City, is the author of three books about breast cancer.

Larry Norton, MD, is the deputy physician-in-chief and director for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center in New York City. He is also the scientific director of the Breast Cancer Research Foundation. Norton's research focuses on clinical trials in breast cancer, the basic biology of cancer and the development of new approaches to diagnose, prevent and treat the disease.

Nancy Roach is the president and founder of C3: Colorectal Cancer Coalition, through which she has spearheaded training programs for gastrointestinal research advocates and worked to increase research funding. She has also served on the faculty of a peer-review training program run by the National Cancer Institute's Consumer Advocates in Research and Related Activities program. A five-year survivor of cervical cancer, Roach lives in Hood River, Ore.

Mary Jackson Scroggins is a co-founder and president of the board of In My Sister's Care, an organization dedicated to eliminating health disparities with a focus on ovarian cancer. She is also the owner and publisher of SisterCircle—a newsletter focused on medically underserved populations. Scroggins, a nine-year survivor of stage IA ovarian cancer, lives in Washington, D.C.

Doug Ulman founded the Ulman Cancer Fund for Young Adults, an organization that provides support, education and resources to young adults affected by cancer. He is also the president of the Lance Armstrong Foundation. Ulman, who lives in Austin, Texas, is a 10-year cancer survivor who has been diagnosed with stage II chondrosarcoma and stage I and stage II melanoma. 

James E. Williams Jr. of Camp Hill, Pa., is the chairman of the Pennsylvania Prostate Cancer Coalition, the chair-elect of the Intercultural Cancer Council and a board member of the Alliance for Prostate Cancer Prevention. Williams serves on committees for several national, regional and local advocacy organizations. He is a retired army colonel and a 15-year survivor of stage II prostate cancer.